Cargando…
The reduction in CVD outcomes with antihypertensives: A mandatory goal
Autor principal: | Gupta, Rajeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414971/ https://www.ncbi.nlm.nih.gov/pubmed/28460784 http://dx.doi.org/10.1016/j.ihj.2017.02.011 |
Ejemplares similares
-
Antihypertensive drugs in COVID-19 infection
por: Pinto-Sietsma, Sara-Joan, et al.
Publicado: (2020) -
Antihypertensive drugs and risk of COVID-19?
por: Lo, Kevin Bryan, et al.
Publicado: (2020) -
Antihypertensive drugs and risk of COVID-19?
por: Brown, Joshua D
Publicado: (2020) -
The Time Is Now for Mandatory Liver‐Focused Clinical Experiences in Medical School
por: Pan, Alexander Y., et al.
Publicado: (2019) -
Mandatory vaccination in child daycare and its relevance to coronavirus disease 2019
por: den Exter, André
Publicado: (2021)